Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic EsophagitisIkuo Hirano, Allen Radin, Kathryn A. Peterson et al.|Gastroenterology|2019Cited by 448
Dupilumab Improves Health-Related Quality of Life (HRQoL) and Reduces Symptom Burden in Patients with Eosinophilic Esophagitis (EoE): Results From Part A of a Randomized, Placebo-Controlled Three-Part Phase 3 StudyEvan S. Dellon, Siddhesh Kamat, Marc E. Rothenberg et al.|Journal of Allergy and Clinical Immunology|2021Cited by 13